The Institut du cancer de Montréal has funded part of the research leading to a promising discovery that will revolutionize the diagnosis of prostate cancer!
Dr Dominique Trudel and Frédéric Leblond, researchers at the Institute and Andrée-Anne Grosset, postdoctoral researcher, collaborated on a recent study published in PLoS Medicine, which combines imaging using Raman microspectroscopy to machine learning techniques to better detect aggressive forms of prostate cancer.
This research, funded in part by the Montreal Cancer Institute, has enabled the identification of patients at risk and the diagnosis of the most aggressive forms of this cancer , because this type of carcinoma is frequently associated with prostate cancer recurrence and metastasis.
Dr Guila Delouya, also a researcher at the Institute, works daily with patients suffering from this type of cancer, and she specifies that this discovery will help clinicians to personalize treatment of patients.
This promising discovery was made possible thanks to the exceptional work of researchers and funding for cancer research!
Institute researchers awarded $1 million grant over 5 years
17 September 2020
Institute researchers win $ 1 million over 5 years from the Canadian Institute for Health Research (CIHR) in the “Spring […]
Anne-Marie Mes-Masson’s team is one of the winning teams of the LeadAction competition | Breast Cancer
14 July 2020
The team of Anne-Marie Mes-Masson, researcher at the Montreal Cancer Institute, is one of the winning teams of the LeadAction […]